Dermavir
Dendritic Cell-Targeting Therapeutic Vaccine. We are a privately held clinical-stage biotechnology company focusing on the development and commercialization of a revolutionary new immune therapy platform for the treatment of chronic viral infections, cancer and allergy. Our technology is designed to boost specific immune response in order to modify or control presently incurable diseases. Our proprietary Vaccine Platform includes a given disease’s antigen specific plasmid DNA (pDNA), a nanomedicine formulation which encapsulates the pDNA to make it closely resemble a virus (we call this combination a nanoparticle), a topical (through the skin) administration device we call DermaPrep which delivers the vaccine via dendritic cell to lymph nodes of the immune system, and a software product which allows us to design antigen specific pDNA and closely match it to a patient’s genetic and HLA profile. The combination of these technologies supports the rapid and cost-effective development of original biologic vaccine products.
I've invested at Dermavir and feel scam here now

If you suspect fraud, it is better to bring it to the attention of the law enforcement authorities. With ICO frauds, every day counts because fraudsters can sweep up the evidence.

Feel free to contact us:
We will help you to find the data about fraud (rate $ 30 per hour). In the future, you can submit this report and the case to any competent lawyer. An example of a research report is available here.

Consult us free of charge about collecting debts from an ICO project bubnov@forensictokenlab.com or via telegram @ICO_Forensic_NOW
We also collect facts about the withdrawal of crypto active assets from the project. If you have any information available about a cryptocurrency, please, send it to us for analysis.

ICO
Project symbol
DER
Link to website
PreICO token price
0.700000 USD
ICO token price
1.000000 USD
Category
Platform
Health
Accepting
ETH
SCROLL
THE STRIP

Genetic Immunity is a US clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of therapeutic vaccines ("Immune Therapies") for the treatment of chronic viral infections (HIV, HPV), cancer and allergies. Our Immune Therapies are designed to intensify and boost specific immune response to modify or control these presently incurable diseases. We believe our products will allow people to live better, healthier and longer lives. Our proprietary immunotherapy platform is composed of an pDNA (plasmid DNA) expressing multiple disease specific antigens, a nanomedicine formulation encapsulating the pDNA and a topical administration device which targets the formulation transdermally to dendritic (Langerhans) cells of the skin. Our platform technologies support the rapid and cost-effective development of novel biologic products for several indications and provides tools for the selection of an optimal, patient specific treatment regimen. Our Lead Product Candidate, a therapeutic vaccine for the treatment of HIV is effective in boosting immune response to kill HIV-infected cells. Our preclinical, Phase I, Phase I/II and Phase II trials have demonstrated HIV-specific T-cells immune response and boosting, and the killing of HIV-infected cells. DermaVir has an excellent safety profile. Our goal is to provide DermaVir as a co-treatment option to antiretroviral therapy (ART), and, upon the completion of an additional clinical trial, to demonstrate efficacy in ART resistant patients, thereby opening a safe, effective new treatment paradigm. In addition to HIV we also work on an extensive pipeline including therapeutic treatments for cancer, the human papillomavirus, MAGE, allergies and more. Please see our pipeline of virus-associated cancers and warts in discovery phase section of the website.

TEAM
Viktor Rozsnyay
Chief Executive Officer
Peter Boros
Chief Operations Officer
ADVISORS
Richard Kastelein
Advisor
Feroz Sanaulla
Advisor
Simon Cocking
Advisor
Ian Scarffe
Advisor
I've invested at Dermavir and feel scam here now

If you suspect fraud, it is better to bring it to the attention of the law enforcement authorities. With ICO frauds, every day counts because fraudsters can sweep up the evidence.

Feel free to contact us:
We will help you to find the data about fraud (rate $ 30 per hour). In the future, you can submit this report and the case to any competent lawyer. An example of a research report is available here.

Consult us free of charge about collecting debts from an ICO project bubnov@forensictokenlab.com or via telegram @ICO_Forensic_NOW
We also collect facts about the withdrawal of crypto active assets from the project. If you have any information available about a cryptocurrency, please, send it to us for analysis.